Abstract
The patient is a 20-year-old man with glycogen storage disease type I (GSD-type I). In his teens, multiple focal hepatic masses were detected on abdominal ultrasonography (US), which were diagnosed as multiple hepatocellular adenomas from the imaging. During follow-up, these masses had shown intermittent growth in size. In the evaluation of Gd-EOB-DTPA (gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid) MR imaging, these masses showed various signal intensities from hypo- to hyperintense during the hepatocyte-specific phase. Intermittent growth and elevation of serum PIVKA-II levels indicate the potential for malignant transformation, so the patient underwent partial hepatectomy. The resected masses were all consistent with benign hepatocellular adenomas histopathologically.
This is a preview of subscription content, log in via an institution to check access.
References
Grazioli L, Federre MP, Brancatelli G, et al. (2001) Hepatic adenomas: imaging and pathologic findings. RadioGraphics 21:877–894
Grazioli L, Federre MP, Ichikawa T, et al. (2000) Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 216:395–402
Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB 7:186–196
Hussain SM, Zondervan PE, IJzermans JNM, et al. (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. RadioGraphics 22:1023–1039
Iijima H, Moriwaki Y, Yamamoto T, et al. (2001) Spontaneous regression of hepatic adenoma in a patient with glycogen storage disease type I after hemodialysis: ultrasonographic and CT findings. Intern Med 40(9):891–895
Farges O, Ddokmak S (2010) Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg 27:32–38
Huppertz A, Haraida S, Kraus A, et al. (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 234:468–478
Giovaloni O, Heim M, Terracciano L, et al. (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR 190:W290–W293
Grazioli L, Morana G, Kirchin MA, et al. (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177
Seale MK, Catalano OA, Saini S, et al. (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. RadioGraphics 29:1725–1748
Frericks BB, Loddenkemper C, Huppertz A, et al. (2009) Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR 193:1053–1060
Saito K, Kotake F, Ito N, et al. (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4(1):1–9
Huppertz A, Balzer T, Blakeborough A, et al. (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275
Narita M, Hatano E, Arizono S, et al. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakamoto, A., Hayashi, H., Sakamoto, I. et al. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imaging 37, 239–243 (2012). https://doi.org/10.1007/s00261-011-9721-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-011-9721-1